Skip to content
Oxcia
Menu
Close
About us
Open menu
About us
Management
Board
Scientific Advisory Board
Collaborators
Partnerships
History
Careers
Scientific Platform
Open menu
Scientific Platform
Glossary
Pipeline
Open menu
Pipeline
OXC-101
OXC-201
Investors
Open menu
Investors
Governance
Ownership structure
Financial reports
Presentations
Upcoming events
Investor contact
Investerare
Open menu
Investerare
Bolagsstyrning
Bolagsstämma
Ägarstruktur
Finansiella rapporter
Pressmeddelanden
Presentationer
Kalender
Investerarkontakt
News and Press
Contact
Search
Home
›
New tablet formulation of karonudib is introduced in the clinical trials
New tablet formulation of karonudib is introduced in the clinical trials
November 18, 2020
Latest news
Kallelse till extra bolagsstämma i Oxcia AB (publ)
September 13, 2023
Sandra Ekstedt presents OXC-201 at the ERS 10th of September
September 4, 2023
Christina Kalderén presents at the IPF Summit September 19-21st
August 31, 2023
Read more news
Search
More results
Generic filters
Search!
